Page last updated: 2024-11-01

omeprazole and Cancer of Stomach

omeprazole has been researched along with Cancer of Stomach in 203 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
" This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection."9.10Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. ( Aoyagi, K; Esaki, M; Fujishima, M; Kuwano, Y; Matsumoto, T; Shimizu, M, 2002)
"Gastric polyps and nodules may be found in children receiving long-term omeprazole therapy."7.71Gastric polyps and nodules in children receiving long-term omeprazole therapy. ( Israel, DM; Pashankar, DS, 2002)
"In patients undergoing long-term treatment with omeprazole, tiny gastric polyps, described histologically as glandular cysts, have occasionally been reported."7.69Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. ( Armbrecht, U; Bethke, B; Goldbrunner, P; Lütke, A; Rabast, U; Seifert, E; Stolte, M, 1995)
"These cases support the possible causal relation between the use of omeprazole and the development of fundic gland polyps in patients without H."7.69Fundic gland polyps developing during omeprazole therapy. ( el-Zimaity, HM; Graham, DY; Jackson, FW, 1997)
" Long term use of proton pump inhibitor (PPI) is known to be associated with certain histological changes of the normal gastric mucosa including parietal cell hyperplasia and fundic gland cysts."5.35[Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]. ( Chae, HS; Cho, YS; Choi, KY; Han, SW; Kim, HK; Kim, JS; Park, YW; Son, HS, 2008)
"The incidence of gastric cancer was investigated in the cohort of persons who used cimetidine in 1977-81."5.28Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users. ( Mosbech, J; Møller, H; Nissen, A, 1992)
" Investigative studies showed evidence for marked and sustained hypergastrinemia increasing on chronic dosing which was capable of restoring gastric acid secretion and pH to near control values."5.27Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole. ( Betton, GR; Buckley, P; Dormer, CS; Pert, P; Price, CA; Wells, T, 1988)
"In this double-blind study, patients with precancerous gastric dysplasia with or without intestinal metaplasia (IM) received either conventional treatment consisting of omeprazole and sucralfate (control group) or conventional treatment plus ATRA."5.20Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia. ( Bai, Y; Chang, Y; Gao, Q; Jiang, Y; Jin, J; Jin, Z; Li, X; Lu, L; Su, X; Wu, L; Xing, L; Zhao, X; Zheng, Y, 2015)
"A total of 158 patients (155 early gastric cancers and three adenomas) were randomly assigned to the PPI group (omeprazole 20 mg/day) or H(2) RA group (famotidine 40 mg/day) in a prospective randomized controlled trial."5.16Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. ( Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T, 2012)
"Forty-eight patients with hyperplastic gastric polyps (3-10 mm in diameter) infected with H pylori were randomly assigned to a treatment group (n = 24) which received proton-pump inhibitor (omeprazole or lansoprazole), clarithromycin, bismuth citrate and tinidazole, and a control group (n = 24) which received protective agent of gastric mucosa (tepretone)."5.12Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. ( Chen, JY; Ji, F; Li, YM; Ning, JW; Wang, QY; Wang, ZW, 2006)
" This study aimed to compare the effects of omeprazole and famotidine on ulcer healing and fibroblast growth factor-2 levels in gastric ulcers induced by endoscopic mucosal resection."5.10Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans. ( Aoyagi, K; Esaki, M; Fujishima, M; Kuwano, Y; Matsumoto, T; Shimizu, M, 2002)
"Of 64 patients with an endoscopically diagnosed gastric adenoma and H pylori infection, 32 were treated with omeprazole and antibiotics to eradicate the infection, and 32 were not."5.09Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. ( Arai, K; Kobayashi, R; Mori, M; Ohki, I; Saito, K, 2000)
" Men between 55 and 65 years of age with a gastric cancer phenotype of Helicobacter pylori gastritis are randomized to receive a 7 day course of omeprazole 2 X 20mg, clarithromycin 2 X 500mg, and amoxicillin 2 X 1g for 7 days, or omeprazole 2 X 20mg plus placebo."5.09Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). ( Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M, 2001)
" pylori infection, indomethacin and their combination affects the healing of gastric ulcers and whether or not such factors provoke a relapse of healed acetic acid ulcers; and 2) whether or not eradication of the bacteria with drugs at specified times after infection prevents the development of mucosal changes, including gastric adenocarcinoma."4.81[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. ( Ebata, M; Keto, Y; Okabe, S, 2001)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
"In our study, oral administration of omeprazole for 1 week was sufficient to achieve healing of ESD-induced artificial gastric ulcers."3.81Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study. ( Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A, 2015)
"Gastric ECL-cell hyperplasia and carcinoids (ECLoma) develop after 1 year in rats treated with omeprazole or 2 months in Mastomys treated with loxtidine."3.78Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine. ( Chen, D; Kidd, M; Modlin, IM; Vigen, RA; Zhao, CM, 2012)
"Gastric polyps and nodules may be found in children receiving long-term omeprazole therapy."3.71Gastric polyps and nodules in children receiving long-term omeprazole therapy. ( Israel, DM; Pashankar, DS, 2002)
"In patients undergoing long-term treatment with omeprazole, tiny gastric polyps, described histologically as glandular cysts, have occasionally been reported."3.69Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. ( Armbrecht, U; Bethke, B; Goldbrunner, P; Lütke, A; Rabast, U; Seifert, E; Stolte, M, 1995)
"These cases support the possible causal relation between the use of omeprazole and the development of fundic gland polyps in patients without H."3.69Fundic gland polyps developing during omeprazole therapy. ( el-Zimaity, HM; Graham, DY; Jackson, FW, 1997)
" 33 patients with primary gastric low-grade MALT lymphoma associated with H pylori gastritis were treated with omeprazole (120 mg daily) and amoxycillin (2."3.69Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. ( Bayerdörffer, E; Eidt, S; Lehn, N; Neubauer, A; Rudolph, B; Stolte, M; Thiede, C, 1995)
" Serious adverse events were not observed in either group."2.80Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m ( Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S, 2015)
"Here we report 14."2.77Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. ( Blot, WJ; Brown, LM; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Han, ZX; Hu, Y; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Shen, L; You, WC; Zhang, L, 2012)
"Incidence of gastric cancer in the two groups was determined based on the results of annual endoscopy and questionnaire surveys, as well as Yamagata Prefectural Cancer Registry data, and was compared between the two groups and by results of H pylori therapy."2.74Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer? ( Fukase, K; Kawata, S; Mabe, K; Matsuda, T; Oizumi, H; Shibata, A; Takahashi, M; Takeda, H; Tsukuma, H, 2009)
"pylori decreases gastric cancer risk, using preneoplastic conditions as surrogate markers."2.71Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Johnstone, I; Ley, C; Mohar, A; Parsonnet, J, 2004)
"pylori in family members of gastric cancer patients."2.71Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients. ( Bueno, ML; Castro, LP; Coelho, LG; Lopes, LG; Martins, GM; Miranda, CH; Passos, MC; Sanches, BS, 2003)
"We found that the incidence of gastric cancer development at the population level was similar between participants receiving H pylori eradication treatment and those receiving placebo during a period of 7."2.71Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. ( Chen, JS; Ching, CK; Feng, RE; Fong, DY; Ho, J; Hu, WH; Lai, KC; Lam, SK; Leung, SY; Wong, BC; Wong, WM; Yuen, ST; Zheng, TT, 2004)
"pylori at 6 wk were infected at 1 yr (recurrence rates 10."2.70Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J, 2002)
"Gastric cancer is the second most frequent cause of death from cancer in the world and the leading cause of death from cancer in China."2.70An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. ( Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Heinrich, J; Liu, WD; Ma, JL; Xu, GW; Yang, CS; You, WC; Zhang, L, 2001)
"He was also diagnosed to have gastric cancer with Helicobacter pylori infection."2.42Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. ( Arima, N; Tsudo, M, 2003)
" However, the consequences of very long-term use of proton pump inhibitors remain unknown."2.41Problems associated with the clinical use of proton pump inhibitors. ( Gillen, D; McColl, KE, 2001)
"ECL-cell carcinoids and gastric cancer occur with a prevalence of 3-7%, and endoscopic surveillance in routine clinical practice is not warranted."2.39Pathophysiological effects of long-term acid suppression in man. ( Arnold, R; Bardhan, KD; Cattan, D; Klinkenberg-Knol, E; Maton, PN; McCloy, RF; Riddell, RH; Sipponen, P; Walan, A, 1995)
"ECL-cell hyperplasia and carcinoids which occur during application of very high doses of omeprazole in rats are not caused by a direct effect of omeprazole."2.38[Risk for developing tumors in therapy with the proton pump inhibitor omeprazole]. ( Arnold, R; Eissele, R, 1993)
"argyrophilic gastric carcinoids."2.38Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. ( Rindi, G; Silini, E; Solcia, E; Villani, L, 1993)
"To date, however, no cases of carcinoid tumor have been attributed to the use of omeprazole in humans."2.38The gastrin hypothesis. Implications for antisecretory drug selection. ( Karnes, WE; Walsh, JH, 1990)
"Gastric carcinoids are slow growing neuroendocrine tumours arising from enterochromaffin-like (ECL) cells in the corpus of stomach."1.46Deletion of ( Choi, EK; Hayes, MM; Kang, AJ; Merchant, JL; Sundaresan, S, 2017)
"A 56-year-old man with gastroesophageal reflux disease (GERD) was referred to our hospital."1.46Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection. ( Abiko, S; Hatanaka, KC; Kato, M; Kudo, T; Matsuda, K; Miyamoto, S; Mizushima, T; Ono, S; Sakamoto, N; Shimizu, Y; Tsuda, M; Tsunematsu, I; Yamamoto, K, 2017)
"pylori-induced gastric cancer, irrespective of the timing of antibiotic administration."1.42Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. ( Aponte-Pieras, JR; Lee, DS; Morrissey, R; Moss, SF; Rogers, AB; Zhang, S, 2015)
" Long term use of proton pump inhibitor (PPI) is known to be associated with certain histological changes of the normal gastric mucosa including parietal cell hyperplasia and fundic gland cysts."1.35[Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole]. ( Chae, HS; Cho, YS; Choi, KY; Han, SW; Kim, HK; Kim, JS; Park, YW; Son, HS, 2008)
"Treatment of human gastric cancer cells with proton pump inhibitors significantly attenuated cell viability in a time- and dose-dependent manner."1.35Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer. ( Cheong, JY; Cho, SW; Kim, DK; Lee, KJ; Park, HJ; Yeo, M, 2008)
"pylori eradication prevented gastric cancer to the greatest extent when antibiotics are given at an early point of infection, but that eradication therapy given at a later time point delayed the development of severe dysplastic lesions."1.35Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. ( Fox, JG; Ge, Z; Lee, CW; Rickman, B; Rogers, AB; Wang, TC, 2008)
"pylori for low-grade MALT lymphoma of the gastric stump without other modalities such as surgery and systemic chemotherapy."1.33Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori. ( Hirakawa, K; Inoue, T; Komoto, M; Nakata, B; Takashima, T; Tominaga, K, 2006)
"Thirty of 79 rats developed gastric cancer, and they were all adenocarcinomas of the Lauren intestinal type."1.32Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. ( Maartmann-Moe, H; Viste, A; Waldum, H; Øvrebø, K, 2004)
"Complete regression of MALT lymphoma following treatment for H."1.32Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. ( Chang, CS; Chang, WD; Chen, GH; Chou, G; Lien, HC; Poon, SK; Yang, SS; Yeh, HZ, 2003)
"pylori treatment on MALT lymphoma and chronic gastritis at the histologic and molecular levels."1.31Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases. ( Begum, S; Endo, H; Kawamata, H; Sano, T; Urakami, Y, 2000)
"Early gastric cancer is frequently seen with nonspecific dyspeptic symptoms and subtle endoscopic features."1.31Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancers. ( Griffin, SM; Hayes, N; Raimes, SA; Wayman, J, 2000)
"Rabeprazole has also been shown to have a more consistent suppression of acid, including at night."1.31Optimizing acid-suppression therapy. ( Barnett, JL; Robinson, M, 2001)
"Complete remission of low-grade gastric MALT lymphoma after the eradication of H."1.31Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation. ( Jung, HC; Kim, CW; Kim, CY; Kim, JS; Kim, YS; Lee, CH; Song, IS, 2002)
"Intramucosal cysts were found in biopsies of non-polypoid gastric body mucosa in 71."1.31Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome. ( Aprile, MR; Azzoni, C; Bordi, C; Gibril, F; Jensen, RT, 2000)
"Endoscopy after ER detected no new gastric cancers in these patients."1.30Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. ( Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S, 1997)
"More than 90% of gastric MALT lymphomas are diagnosed in patients with chronic, Helicobacter pylori-associated gastritis."1.30Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. ( Alpen, B; Bayerdörffer, E; Ehninger, G; Morgner, A; Neubauer, A; Neubauer, B; Ritter, M; Stolte, M; Thiede, C; Wündisch, T, 1997)
"Staging of gastric low-grade MALT lymphomas by endoscopic ultrasonography allows prediction of the response to therapy by eradication of H."1.30Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. ( Bayerdoerffer, E; Boersch, G; Kraemer, W; Morgner, A; Neubauer, A; Rohde, P; Rudolph, B; Sackmann, M; Schulz, H; Seifert, E; Stolte, M; Thiede, C, 1997)
" Long-term use of proton pump inhibitors may be associated with the presence of small gastric fundic gland polyps and hyperplastic polyps."1.30Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. ( Boyce, HW; Choudhry, U; Coppola, D, 1998)
"None of the rats developed esophageal cancer, but esophageal mucosal hyperplasia was more pronounced in rats receiving omeprazole."1.30Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. ( Adrian, TE; Hinder, RA; Perdikis, G; Profanter, C; Smyrk, T; Wetscher, GJ, 1999)
"A subset of H."1.30Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. ( Cabanillas, FF; Ford, R; Genta, RM; Glober, G; Graham, DY; Hagemeister, FB; Johnson, CM; Lahoti, S; Lee, JE; Luthra, R; Lynch, PM; Manning, JT; McLaughlin, PW; Rodriguez, MA; Romaguera, JE; Sample, D; Sarris, AH; Shen, Y; Steinbach, G; Winn, RJ; Younes, A, 1999)
"pylori)with an increased risk of gastric cancer has been well documented, the exact mechanisms of this association have not been fully elucidated."1.30Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication. ( Antoniades, D; Kalafatis, E; Karameris, A; Lazaris, A; Liatsos, C; Petridou, E; Rokkas, T, 1999)
"Development of gastric cancer, however, has not been obvious in clinical and experimental studies, but oncongenicity studies indicate an increased risk of gastric cancer with long-term use of proton pump inhibitors in subjects with hyperplastic or other, changes in the gastric mucosa."1.28[Treatment of gastric ulcers with proton pump inhibitors--long-term treatment]. ( Akimoto, H; Aoki, T; Takayama, S, 1992)
"The incidence of gastric cancer was investigated in the cohort of persons who used cimetidine in 1977-81."1.28Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users. ( Mosbech, J; Møller, H; Nissen, A, 1992)
"However, no carcinoid tumors were observed, possibly because the strain of mastomys studied does not produce carcinoids spontaneously."1.28The effect of omeprazole-induced hypergastrinemia on the oxyntic mucosa of mastomys. ( Brenna, E; Håkanson, R; Sandvik, AK; Sundler, F; Waldum, HL, 1991)
"Neuroendocrine cell (carcinoid) tumours have been reported in the acid-secreting part of the stomach of rodents after long-term administration of a range of potent chemically diverse antisecretory agents."1.28Potential hazards of long-term acid suppression. ( Selway, SA, 1990)
" Investigative studies showed evidence for marked and sustained hypergastrinemia increasing on chronic dosing which was capable of restoring gastric acid secretion and pH to near control values."1.27Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole. ( Betton, GR; Buckley, P; Dormer, CS; Pert, P; Price, CA; Wells, T, 1988)
"Omeprazole is a long acting inhibitor of gastric acid secretion in different species including rat and dog."1.27Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa. ( Carlsson, E; Larsson, H; Mattsson, H; Ryberg, B; Sundell, G, 1986)
"The tumours could be defined as carcinoids of enterochromaffin-like (ECL) cell origin."1.27Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. ( Havu, N, 1986)

Research

Studies (203)

TimeframeStudies, this research(%)All Research%
pre-199014 (6.90)18.7374
1990's76 (37.44)18.2507
2000's88 (43.35)29.6817
2010's20 (9.85)24.3611
2020's5 (2.46)2.80

Authors

AuthorsStudies
Crafa, P1
Franceschi, M1
Rodriguez-Castro, KI1
Franzoni, L1
Russo, M1
Brandimarte, G1
Tursi, A3
Rugge, M1
Di Mario, F1
Gingold-Belfer, R1
Issa, N1
Boltin, D1
Beloosesky, Y1
Koren-Morag, N1
Meyerovitch, J1
Sharon, E1
Peleg, N1
Schmilovitz-Weiss, H1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J2
Zhang, J2
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J7
Xue, L1
Liu, L2
Yan, X3
Huang, S1
Li, Y7
Xu, T1
Li, C2
Ji, F2
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X2
Chen, Y5
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y4
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH3
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y2
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q3
Guo, X1
Cao, Y1
Jia, X1
Xu, S1
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X5
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y5
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X4
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM2
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X1
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Liu, Y2
Zhang, Q2
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH2
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X1
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z2
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H3
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y1
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L2
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C1
Zhang, X1
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Howden, CW1
Graham, DY4
Feng, S1
Qiu, G1
Yang, L1
Fan, X1
Ren, F1
Huang, K1
Miyamoto, S1
Kato, M3
Matsuda, K1
Abiko, S1
Tsuda, M1
Mizushima, T1
Yamamoto, K1
Ono, S2
Kudo, T1
Shimizu, Y2
Hatanaka, KC1
Tsunematsu, I1
Sakamoto, N1
Salar, A1
Huang, N1
Luo, H1
He, H1
Ding, M1
Deng, WQ1
Zou, K1
Zhou, L1
Lin, S1
Ding, S1
Huang, X1
Jin, Z2
Cui, R1
Meng, L1
Zhang, L8
Guo, C1
Xue, Y1
Li, WQ1
Ma, JL7
Brown, LM5
Li, JY6
Shen, L4
Pan, KF5
Liu, WD6
Han, ZX2
Crystal-Mansour, S3
Pee, D3
Blot, WJ4
Fraumeni, JF5
You, WC7
Gail, MH5
Higuchi, K1
Takeuchi, T1
Uedo, N1
Takeuchi, Y1
Naito, Y2
Yagi, N1
Tominaga, K2
Machida, H1
Tamada, T1
Morita, Y2
Yazumi, S1
Yamao, J1
Iguchi, M1
Azuma, T2
Jin, J1
Xing, L1
Chang, Y1
Wu, L1
Su, X1
Bai, Y1
Zheng, Y1
Jiang, Y1
Lu, L1
Zhang, S1
Lee, DS1
Morrissey, R1
Aponte-Pieras, JR1
Rogers, AB2
Moss, SF1
Kajiura, S1
Hosokawa, A1
Ueda, A1
Mihara, H1
Ando, T1
Fujinami, H1
Nishikawa, J1
Ogawa, K2
Minemura, M1
Sugiyama, T1
Zhou, T1
Nandy, N1
Hanson, JA1
Strickland, RG1
McCarthy, DM1
Sundaresan, S1
Kang, AJ1
Hayes, MM1
Choi, EK1
Merchant, JL1
Kim, JS3
Chae, HS1
Kim, HK1
Cho, YS1
Park, YW1
Son, HS1
Han, SW1
Choi, KY1
Ono, Y1
Nakagawa, M1
Nakagawa, S1
Asaka, M3
Mabe, K1
Takahashi, M1
Oizumi, H1
Tsukuma, H1
Shibata, A1
Fukase, K1
Matsuda, T1
Takeda, H1
Kawata, S1
Familiar, C1
Antón, T1
Moraga, I1
Ramos, A1
Marco, A1
Al Furaikh, SS1
Kim, JY1
Kim, N1
Park, HK1
Jo, HJ1
Shin, CM1
Lee, SH1
Park, YS1
Hwang, JH1
Kim, JW1
Lee, DH1
Nam, RH1
Kim, JM1
Lee, JH2
Jung, HC3
Song, IS3
Wong, BC2
Feng, GS1
Zhang, XD1
Lu, AP1
Xia, HH1
Lam, S1
Chelly, I1
Adouni, O1
Chouaib, S1
Azouz, H1
Nfoussi, H1
Haouet, S1
Zitouna, M1
Kchir, N1
Tomita, T1
Kim, Y1
Yamasaki, T1
Okugawa, T1
Kondo, T1
Toyoshima, F1
Sakurai, J1
Tanaka, J2
Morita, T1
Oshima, T1
Fukui, H1
Hori, K1
Watari, J1
Matsumoto, T2
Miwa, H1
Vigen, RA1
Kidd, M1
Modlin, IM1
Chen, D1
Zhao, CM1
Mohar, A2
Ley, C2
Guarner, J2
Herrera-Goepfert, R2
Figueroa, LS2
Halperin, D2
Parsonnet, J2
Pashankar, DS1
Israel, DM1
Coelho, LG2
Martins, GM2
Passos, MC2
Bueno, ML2
Sanches, BS1
Lopes, LG2
Miranda, CH1
Castro, LP2
Wepner, U1
Yeh, HZ2
Chen, GH2
Chang, WD1
Poon, SK1
Yang, SS2
Lien, HC1
Chang, CS1
Chou, G1
Arima, N1
Tsudo, M1
Hiramoto, JS1
Terdiman, JP1
Norton, JA1
Yamamoto, T1
Matsumoto, J1
Kosaihira, T1
Nomoto, M1
Kitajima, S1
Arima, T1
Takahashi, S2
Fischbach, W2
Goebeler-Kolve, ME1
Dragosics, B2
Greiner, A2
Stolte, M12
Lam, SK1
Wong, WM1
Chen, JS2
Zheng, TT1
Feng, RE1
Lai, KC1
Hu, WH1
Yuen, ST1
Leung, SY1
Fong, DY1
Ho, J1
Ching, CK1
Johnstone, I1
Hamaguchi, K1
Katsube, T1
Konno, S1
Aiba, M1
Viste, A1
Øvrebø, K1
Maartmann-Moe, H1
Waldum, H1
Lee, SY1
Kim, JJ1
Rhee, PL1
Paik, SW1
Rhee, JC1
Leung, WK1
Lin, SR1
Ching, JY1
To, KF1
Ng, EK1
Chan, FK1
Lau, JY1
Sung, JJ1
Agar, M1
Webster, R1
Lacey, J1
Donovan, B1
Walker, A1
Yeo, M2
Kim, DK2
Kim, YB1
Oh, TY1
Lee, JE2
Cho, SW2
Kim, HC1
Hahm, KB1
Maruta, F1
Sugiyama, A1
Ishizone, S1
Miyagawa, S1
Ota, H1
Katsuyama, T2
de Mascarel, A3
Ruskone-Fourmestraux, A2
Lavergne-Slove, A2
Megraud, F3
Dubus, P1
Merlio, JP1
Attila, T1
Santharam, R1
Blom, D1
Komorowski, R1
Koch, TR1
Tanabe, H1
Hara, H1
Ohtubo, C1
Miyokawa, N1
Sano, H1
Yamaguchi, Y1
Katsumi, N1
Tauchi, M1
Toki, M1
Nakamura, K1
Aoki, K1
Miura, M1
Morozumi, K1
Ishida, H1
Chen, LT2
Lin, JT2
Tai, JJ1
Wang, HP1
Kuo, SH1
Sheu, BS1
Jan, CM2
Wang, TE1
Wu, CW1
Chen, CL2
Su, IJ2
Whang-Peng, J1
Cheng, AL2
Wöhrer, S1
Bartsch, R1
Hejna, M1
Drach, J1
Raderer, M1
Shimizu, N1
Kubota, K1
Kaminishi, M1
Brzozowski, T1
Konturek, PC1
Mierzwa, M1
Drozdowicz, D1
Bielanski, W1
Kwiecien, S1
Konturek, SJ1
Stachura, J1
Pawlik, WW1
Hahn, EG1
Kim, MS1
Jung, HK1
Jung, HS1
Choi, JY1
Na, YJ1
Pyun, GW1
Ryu, JH1
Moon, IH1
Jo, MS1
Onoda, N1
Katsuragi, K1
Sawada, T1
Maeda, K1
Mino, A1
Ohira, M1
Ishikawa, T1
Wakasa, K1
Hirakawa, K2
Wang, ZW1
Ning, JW1
Wang, QY1
Chen, JY1
Li, YM1
Kikuchi, S1
Tominaga, S1
Jin, ML2
Chang, YS3
Xu, GW3
Robb-Nicholson, C1
Komoto, M1
Nakata, B1
Takashima, T1
Inoue, T1
Ye, BD1
Cheon, JH1
Choi, KD1
Kim, SG1
Handa, O1
Yoshida, N1
Fujita, N1
Tanaka, Y1
Ueda, M1
Takagi, T1
Kokura, S1
Okanoue, T1
Yoshikawa, T1
Kawamura, O1
Kusano, M1
Shimoyama, Y1
Horikoshi, T1
Sekiguchi, T1
Mori, M2
Przemeck, SM1
Varro, A1
Berry, D1
Steele, I1
Wang, TC2
Dockray, GJ1
Pritchard, DM1
Park, HJ1
Cheong, JY1
Lee, KJ1
Cavanna, L1
Pagani, R1
Seghini, P1
Zangrandi, A1
Paties, C1
Lee, CW1
Rickman, B1
Ge, Z1
Fox, JG1
Demling, L1
Levine, JB1
Solcia, E3
Rindi, G2
Silini, E1
Villani, L1
Waldum, HL4
Brenna, E3
Reed, PI1
Bethke, B1
Seifert, E3
Armbrecht, U1
Lütke, A1
Goldbrunner, P1
Rabast, U1
Bayerdörffer, E4
Neubauer, A7
Rudolph, B2
Thiede, C5
Lehn, N1
Eidt, S2
Handa, Y1
Ietomi, K1
Sakimura, K1
Miyoshi, K1
McCloy, RF1
Arnold, R3
Bardhan, KD2
Cattan, D1
Klinkenberg-Knol, E1
Maton, PN1
Riddell, RH1
Sipponen, P1
Walan, A1
tho Pesch, S1
Müller, W1
Borchard, F1
Peters, U1
Montalban, C1
Manzanal, A1
Boixeda, D1
Redondo, C1
Bellas, C1
Fujimoto, K1
Iwakiri, R1
Koyama, T1
Sakata, H1
Ohyama, T1
Mizuguchi, M1
Tokunaga, O1
Freston, JW2
Muller, AF1
Pinder, S1
Toghill, PJ1
Imoto, I1
Suzuki, S2
Eissele, R1
Reddrop, CJ1
Cammarota, G3
Montalto, M1
Papa, A2
Branca, G1
Vecchio, FM1
Renzi, C1
Verzí, A1
Armuzzi, A1
Pretolani, S1
Davis, S1
Roesch, W1
Repucci, AH1
Muñoz, N1
Vivas, J1
Buiatti, E1
Kato, I1
Oliver, W1
Rubin, CE1
Seko, A1
Amano, K1
Shimizu, H1
Takagi, S1
Goto, A1
Kondo, H2
Sugie, S1
Yoshimi, N1
Moriwaki, H1
Muto, Y1
Axon, AT2
O'Moráin, CA1
Crowe, JP1
Beattie, AD1
Thompson, RP1
Smith, PM1
Hollanders, FD1
Baron, JH1
Lynch, DA1
Dixon, MF1
Tompkins, DS1
Birrell, H1
Gillon, KR1
Martin, J1
Boyle, S1
Jacyna, M1
Uemura, N1
Mukai, T1
Okamoto, S1
Yamaguchi, S1
Mashiba, H1
Taniyama, K1
Sasaki, N1
Haruma, K2
Sumii, K2
Kajiyama, G1
Morgner, A3
Alpen, B2
Ritter, M1
Neubauer, B1
Wündisch, T2
Ehninger, G3
Sackmann, M1
Schulz, H1
Kraemer, W1
Boersch, G1
Rohde, P1
Bayerdoerffer, E1
el-Zimaity, HM1
Jackson, FW1
Declich, P5
Sironi, M1
Matsunaga, K1
Oofukuji, M1
Syukuwa, S1
Osabe, M1
Takeno, Y1
Isomoto, H1
Mizuta, Y1
Kohno, S1
Graham, JR2
Ohtsu, T1
Boku, N1
Cannizzaro, O1
Cuoco, L1
Cianci, R2
Fedeli, P1
Fedeli, G1
Gasbarrini, G2
Haga, Y1
Nakatsura, T1
Shibata, Y1
Sameshima, H1
Nakamura, Y1
Tanimura, M1
Ogawa, M1
Sonnenberg, A1
Delcò, F1
El-Serag, HB1
Nobre-Leitão, C1
Lage, P1
Cravo, M1
Cabeçadas, J1
Chaves, P1
Alberto-Santos, A1
Correia, J1
Soares, J1
Costa-Mira, F1
Naegels, S1
Urbain, D1
Wayman, J2
Hayes, N2
Griffin, SM2
Groves, FD1
Heinrich, JP1
Hu, J1
Mark, SD1
Rabkin, CS1
Weilert, F1
Smith, AC1
Stokes, PL1
Ferrara, A1
Galati, F1
Caruso, S1
Baldacci, MP1
Ambrosiani, L3
De Mas, CR1
Choudhry, U1
Boyce, HW1
Coppola, D1
Ohkusa, T1
Takashimizu, I1
Fujiki, K1
Shimoi, K1
Horiuchi, T1
Sakurazawa, T1
Ariake, K1
Ishii, K1
Kumagai, J1
Tanizawa, T1
Terano, A1
Udvardy, M1
Wetscher, GJ1
Hinder, RA1
Smyrk, T1
Perdikis, G1
Adrian, TE1
Profanter, C1
Steinbach, G1
Ford, R1
Glober, G1
Sample, D1
Hagemeister, FB1
Lynch, PM1
McLaughlin, PW1
Rodriguez, MA1
Romaguera, JE1
Sarris, AH1
Younes, A1
Luthra, R1
Manning, JT1
Johnson, CM1
Lahoti, S1
Winn, RJ1
Genta, RM1
Cabanillas, FF1
Labenz, J2
Sandvik, AK2
Lund, H1
Bellone, S3
Tavani, E3
Prada, A2
Bortoli, A2
Gozzini, C2
Gonzalez Cueto, D1
Bruno, S1
Bustos Fernandez, LM1
Narbaitz, M1
Rokkas, T1
Liatsos, C1
Karameris, A1
Petridou, E1
Lazaris, A1
Antoniades, D1
Kalafatis, E1
Gotoda, T1
Saito, D1
Ono, H1
Oda, I1
Fujishiro, M1
Yamaguchi, H1
Ng, WW1
Lam, CP1
Chau, WK1
Fen-Yau Li, A1
Huang, CC1
Chang, FY1
Lee, SD1
de Mestier, P1
Aprile, MR1
Azzoni, C1
Gibril, F1
Jensen, RT1
Bordi, C1
Gomes, BS1
Begum, S1
Sano, T1
Endo, H1
Kawamata, H1
Urakami, Y1
Viani, F1
Siegrist, HH1
Pignatelli, B1
Cederberg, C1
Idström, JP1
Verdu, EF1
Fried, M1
Blum, AL1
Armstrong, D1
Adamsson, I1
Edlund, C1
Nord, CE1
Raimes, SA1
Nakajima, A1
Matsuhashi, N1
Yazaki, Y1
Oka, T1
Sugano, K1
Grassini, R2
Moayyedi, P1
Feltbower, R1
Crocombe, W1
Mason, S1
Atha, P1
Brown, J1
Dowell, AC1
Richards, ID1
Saito, K1
Arai, K1
Kobayashi, R1
Ohki, I1
Weinstein, WM1
Dawson, R1
Manson, JM1
Lavergne, A2
Aegerter, PH1
Palazzo, L1
Molina, T1
Rambaud, JL1
Miki, H1
Kobayashi, S1
Harada, H1
Yamanoi, Y1
Uraoka, T1
Sotozono, M1
Ohmori, M1
Kato, K1
Sugitani, M1
Nagata, T1
Nishinarita, S1
Kawamura, F1
Takahashi, Y1
Ishii, Y1
Kawamura, Y1
Komuro, S1
Yanai, M1
Nemoto, N1
Arakawa, Y1
Miehlke, S2
Schmitt, W1
Müller-Hermelink, H1
Schetelig, J1
Hiyama, T1
Kitadai, Y1
Ito, M1
Masuda, H1
Miyamoto, M1
Tanaka, S1
Yoshihara, M1
Shimamoto, F1
Chayama, K1
Porcellati, M1
Daniels, IR1
Heinrich, J1
Yang, CS1
Suto, H1
Ito, Y1
Ohtani, M1
Dojo, M1
Kuriyama, M1
Kato, T1
Vermeer, IT1
Engels, LG1
Pachen, DM1
Dallinga, JW1
Kleinjans, JC1
van Maanen, JM1
Kume, K1
Hirakoba, M1
Murata, I1
Yoshikawa, I1
Otsuki, M1
Ribeiro, JM1
Lucas, M1
Palhano, MJ1
Victorino, RM1
Tankovic, J1
Lamarque, D1
Lascols, C1
Soussy, CJ1
Delchier, JC2
Keto, Y1
Ebata, M1
Okabe, S1
Geboes, K1
Dekker, W1
Mulder, CJ1
Nusteling, K1
Salam, I1
Durai, D1
Murphy, JK1
Sundaram, B1
Shyu, RY1
Chiang, IP1
Liu, SM1
Barnett, JL1
Robinson, M1
Röbbecke, J1
Kirsch, C1
Gschwantler, M1
Oberhuber, G1
Antos, D1
Dite, P1
Läuter, J1
Leodolter, A1
Malfertheiner, P2
Kim, YS1
Lee, CH1
Kim, CW1
Kim, CY1
Lamberts, R1
Brunner, G1
O'Morain, C1
Hungin, AP1
Jones, R1
Axon, A1
Tytgat, G1
Levy, M1
Copie-Bergman, C1
Traulle, C1
Brousse, N1
Flejou, JF1
Hemery, F1
Gaulard, P1
Gillen, D1
McColl, KE1
Esaki, M1
Aoyagi, K1
Kuwano, Y1
Shimizu, M1
Fujishima, M1
Aoki, T1
Akimoto, H1
Takayama, S1
Møller, H1
Nissen, A1
Mosbech, J1
Dent, J1
Langman, MJ1
Tielemans, YK1
Willems, GE1
Håkanson, R1
Sundler, F1
Miederer, SE1
Berlin, RG1
Cadiot, G1
Lehy, T1
Ruszniewski, P1
Sobhani, I1
Vallot, T1
Mignon, M1
Bonfils, SJ1
Selway, SA1
Karnes, WE1
Walsh, JH1
Havu, N3
Elm, G1
Goldfain, D1
le Bodic, MF1
Galian, A1
Modigliani, R1
Wormsley, KG1
Daly, MJ2
Pottage, A2
Elder, JB1
Betton, GR1
Dormer, CS1
Wells, T1
Pert, P1
Price, CA1
Buckley, P1
Koop, H1
Carlsson, E2
Larsson, H1
Mattsson, H1
Ryberg, B1
Sundell, G1
Ekman, L1
Hansson, E1
Lundberg, C1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial[NCT02541864]330 participants (Actual)Interventional2013-07-31Completed
Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection - a Randomized Controlled Trial (REHYTRI Study)[NCT02359435]440 participants (Actual)Interventional2012-10-31Completed
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type of The Stomach[NCT00201422]70 participants (Actual)Interventional1996-06-30Completed
PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents (PROTOCOL)[NCT05817721]639 participants (Anticipated)Observational2023-05-05Recruiting
Treatment of Low-Grade Gastric Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study)[NCT00154440]Phase 3200 participants Interventional2001-11-30Recruiting
Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis[NCT01524757]48 participants (Anticipated)Interventional2012-03-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants in Which H. Pylori Was Eradicated

Repeated endoscopy with rapid urease test, histological examination and culture or urea breath tests are conducted to assess H. pylori status. (NCT02541864)
Timeframe: at the 6th week after the end of anti- H. pylori therapy

Interventionparticipants (Number)
Pantoprazole+Bismuth+Tetra+Metro154
Hybrid Therapy154

Number of Participants in Which H. Pylori Was Eradicated

Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02359435)
Timeframe: at the 6th week after the end of anti- H. pylori therapy

Interventionparticipants (Number)
Reverse Hybrid Therapy206
Standard Triple Therapy191

Reviews

32 reviews available for omeprazole and Cancer of Stomach

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Gastric MALT lymphoma and Helicobacter pylori.
    Medicina clinica, 2019, 01-18, Volume: 152, Issue:2

    Topics: Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Ther

2019
Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:3

    Topics: Aged; Carcinoid Tumor; Endoscopy, Digestive System; Humans; Male; Omeprazole; Proton Pump Inhibitors

2016
[About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Combined Modality Therapy; Duodenal Neopla

2011
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
    British journal of haematology, 2003, Volume: 120, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug The

2003
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.
    Surgical oncology, 2003, Volume: 12, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; D

2003
[Guidelines in the management of Helicobacter pylori infection in Japan].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gas

2003
[A case of gastric fundic polyps during long-term treatment of reflux esophagitis with omeprazole].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2003, Volume: 100, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis, Peptic; Female; Gastric Fundus; Humans; Ome

2003
[The treatment of Helicobacter pylori infection in upper gastrointestinal disorders].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2003, Volume: 100, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clinical Trials as Topic; Dyspepsia; Gastritis; Gastrointes

2003
[Eradication of Helicobacter pylori].
    Krankenpflege Journal, 2005, Volume: 43, Issue:4-6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy,

2005
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; En

2005
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.
    World journal of surgical oncology, 2008, Mar-19, Volume: 6

    Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter

2008
Pharmacologic options for the control of peptic ulcer disease.
    Advances in internal medicine, 1984, Volume: 30

    Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; His

1984
Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
    Bailliere's clinical gastroenterology, 1993, Volume: 7, Issue:1

    Topics: Animals; Carcinoid Tumor; Enterochromaffin Cells; Gastric Acid; Gastric Mucosa; Gastrins; Gastritis;

1993
Pathophysiological effects of long-term acid suppression in man.
    Digestive diseases and sciences, 1995, Volume: 40, Issue:2 Suppl

    Topics: Aging; Anemia, Pernicious; Enterochromaffin Cells; Female; Gastric Acid; Histamine H2 Antagonists; H

1995
[Risk for developing tumors in therapy with the proton pump inhibitor omeprazole].
    Versicherungsmedizin, 1993, Aug-01, Volume: 45, Issue:4

    Topics: Animals; Carcinogenicity Tests; Carcinoid Tumor; Esophagitis, Peptic; Humans; Omeprazole; Peptic Ulc

1993
Triple therapy and Helicobacter pylori.
    Australian family physician, 1996, Volume: 25, Issue:1

    Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination;

1996
Cost-effectiveness of H. pylori eradication.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1996, Volume: 47, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Helicobacter

1996
[Gastric solitary plasmacytoma associated with +Helicobacter pylori infection].
    Acta gastroenterologica Latinoamericana, 1999, Volume: 29, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Mucosa; Helicobacter I

1999
Microbial ecology and treatment of Helicobacter pylori infections: review.
    Journal of chemotherapy (Florence, Italy), 2000, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin;

2000
Fundic gland polyps: a still elusive entity on the eve of the year 2000.
    Polish journal of pathology : official journal of the Polish Society of Pathologists, 2000, Volume: 51, Issue:1

    Topics: Adenomatous Polyposis Coli; Anti-Ulcer Agents; Female; Gardner Syndrome; Gastric Fundus; Gastric Muc

2000
Proton pump inhibitors and H. pylori infection: why the concern?
    Current gastroenterology reports, 1999, Volume: 1, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Enzyme Inhibitors; Gastritis, Atrophic;

1999
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2001, Volume: 118, Issue:4

    Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer

2001
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:2

    Topics: Adult; Anti-Ulcer Agents; Child; Duodenal Ulcer; Germany; Helicobacter Infections; Helicobacter pylo

2002
Problems associated with the clinical use of proton pump inhibitors.
    Pharmacology & toxicology, 2001, Volume: 89, Issue:6

    Topics: Animals; Anti-Ulcer Agents; Carcinoid Tumor; Gastric Acid; Gastritis, Atrophic; Helicobacter Infecti

2001
Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy.
    Digestion, 1992, Volume: 51 Suppl 1

    Topics: Colonic Neoplasms; Drug Monitoring; Fasting; Gastric Mucosa; Gastrins; Humans; Omeprazole; Ranitidin

1992
[Growth factors of enterochromaffin-like cells and physiopathology of experimental carcinoid tumors].
    Gastroenterologie clinique et biologique, 1991, Volume: 15, Issue:5 ( Pt 2)

    Topics: Animals; Clofibric Acid; Enterochromaffin Cells; Female; Fibric Acids; Gastric Mucosa; Gastrins; Gro

1991
[Anomalies of fundic argyrophil cell proliferation (enterochromaffin-like cells) in Zollinger-Ellison syndrome].
    Gastroenterologie clinique et biologique, 1991, Volume: 15, Issue:5 ( Pt 2)

    Topics: Carcinoid Tumor; Enterochromaffin Cells; Female; Gastrins; Humans; Male; Omeprazole; Pyloric Antrum;

1991
[From acid secretion inhibition to enterochromaffin-like cell proliferation. Traps on the path].
    Gastroenterologie clinique et biologique, 1991, Volume: 15, Issue:5 ( Pt 2)

    Topics: Adenocarcinoma; Carcinoid Tumor; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Gastritis, Atroph

1991
The gastrin hypothesis. Implications for antisecretory drug selection.
    Journal of clinical gastroenterology, 1990, Volume: 12 Suppl 2

    Topics: Achlorhydria; Animals; Carcinoid Tumor; Cell Transformation, Neoplastic; Enterochromaffin Cells; Gas

1990
Therapeutic achlorhydria and risk of gastric cancer.
    Gastroenterologia Japonica, 1989, Volume: 24, Issue:5

    Topics: Animals; Biomechanical Phenomena; Carcinogens; Esophagitis; Gastric Acid; Humans; Omeprazole; Peptic

1989
Inhibition of acid and gastric carcinoids.
    Gut, 1985, Volume: 26, Issue:12

    Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Mucosa; Histamine H2 Antag

1985

Trials

41 trials available for omeprazole and Cancer of Stomach

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
    Chinese medical journal, 2014, Volume: 127, Issue:8

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Follow

2014
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015, Volume: 18, Issue:3

    Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female;

2015
Addition of all-trans-retinoic acid to omeprazole and sucralfate therapy improves the prognosis of gastric dysplasia.
    The Journal of international medical research, 2015, Volume: 43, Issue:2

    Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Humans; Intesti

2015
Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
    Carcinogenesis, 2015, Volume: 36, Issue:12

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; China; Clarithromycin; Cyclooxygenase 2; Cyclo

2015
Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
    Endoscopy, 2009, Volume: 41, Issue:4

    Topics: Administration, Oral; Aged; Anti-Ulcer Agents; Drug Administration Schedule; Female; Follow-Up Studi

2009
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
    World journal of gastroenterology, 2009, Sep-14, Volume: 15, Issue:34

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An

2009
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Gut, 2012, Volume: 61, Issue:6

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; Clarithromycin; Cyclooxygenase 2 Inhibitors; D

2012
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
    Journal of the National Cancer Institute, 2012, Mar-21, Volume: 104, Issue:6

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; China; Confounding Factors, Epidemio

2012
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:9

    Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric

2012
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:10

    Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial;

2002
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients.
    Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Ag

2003
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Gut, 2004, Volume: 53, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Co

2004
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    JAMA, 2004, Jan-14, Volume: 291, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin

2004
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    JAMA, 2004, Jan-14, Volume: 291, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin

2004
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    JAMA, 2004, Jan-14, Volume: 291, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin

2004
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    JAMA, 2004, Jan-14, Volume: 291, Issue:2

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Anti-Ulcer Agents; Chin

2004
Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Gastritis; Helicobacter Infec

2004
Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole.
    Gastrointestinal endoscopy, 2004, Volume: 60, Issue:2

    Topics: Adenoma; Aged; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Female; Humans; Male; Omeprazole; Pro

2004
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Gut, 2004, Volume: 53, Issue:9

    Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination

2004
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: Aged; Anti-Ulcer Agents; Cost-Benefit Analysis; Endoscopy, Gastrointestinal; Famotidine; Female; Gas

2005
Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.
    World journal of gastroenterology, 2006, Mar-21, Volume: 12, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar

2006
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
    Helicobacter, 2006, Volume: 11, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial

2006
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    Journal of the National Cancer Institute, 2006, Jul-19, Volume: 98, Issue:14

    Topics: Adult; Amoxicillin; Ascorbic Acid; China; Disease Progression; Double-Blind Method; Drug Therapy, Co

2006
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
    Alimentary pharmacology & therapeutics, 2006, Sep-01, Volume: 24, Issue:5

    Topics: Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Hum

2006
Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:9

    Topics: Adenoma; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Endoscopy, Gastrointes

2007
The ECP-IM intervention study.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 1994, Volume: 3 Suppl 2

    Topics: Ascorbic Acid; Clarithromycin; Double-Blind Method; Drug Combinations; Europe; Female; Helicobacter

1994
Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.
    Journal of clinical gastroenterology, 1995, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Aged; Amoxicillin; Antitrichomonal Agents; Drug Therapy, Combination; Female; Hel

1995
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
    IARC scientific publications, 1996, Issue:139

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromyc

1996
Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection.
    BMJ (Clinical research ed.), 1997, Feb-22, Volume: 314, Issue:7080

    Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Female; Follow-Up Studies; Helicobacter

1997
Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
    Controlled clinical trials, 1998, Volume: 19, Issue:4

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Ascorbic Acid; China; Double-Blind Method; Drug Therapy, Comb

1998
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
    Annals of internal medicine, 1998, Nov-01, Volume: 129, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents;

1998
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
    Zeitschrift fur Gastroenterologie, 1999, Volume: 37, Issue:7

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Et

1999
Once-daily Helicobacter pylori treatment to family members of gastric cancer patients.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Dose-Response Rel

2000
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:6

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clari

2000
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma.
    Gastrointestinal endoscopy, 2000, Volume: 52, Issue:1

    Topics: Adenoma; Aged; Aged, 80 and over; Amoxicillin; Carcinoma; Cell Transformation, Neoplastic; Clarithro

2000
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2001, Volume: 10, Issue:3

    Topics: Adult; Aged; Amoxicillin; Antioxidants; Ascorbic Acid; beta Carotene; China; Double-Blind Method; Dr

2001
Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Drug Administration Schedule; Endoscopy; Enzyme Inhib

2001
Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Aged; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Gastr

2001
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
    World journal of gastroenterology, 2001, Volume: 7, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointe

2001
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:2

    Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithro

2002
Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:4

    Topics: Aged; Anti-Ulcer Agents; Endoscopy; Famotidine; Female; Fibroblast Growth Factor 2; Humans; Male; Mi

2002
Omeprazole.
    The Medical letter on drugs and therapeutics, 1990, Mar-09, Volume: 32, Issue:813

    Topics: Animals; Carcinoid Tumor; Clinical Trials as Topic; Gastric Acid; Gastroesophageal Reflux; Humans; O

1990
Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole.
    Scandinavian journal of gastroenterology. Supplement, 1989, Volume: 166

    Topics: Biopsy; Carcinoid Tumor; Cell Division; Cell Transformation, Neoplastic; Enterochromaffin Cells; Eso

1989

Other Studies

131 other studies available for omeprazole and Cancer of Stomach

ArticleYear
PPIs and gastric cancer: any causal relationship?
    Acta bio-medica : Atenei Parmensis, 2023, 06-14, Volume: 94, Issue:3

    Topics: Causality; Gastritis, Atrophic; Humans; Omeprazole; Proton Pump Inhibitors; Stomach Neoplasms

2023
Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use.
    European journal of gastroenterology & hepatology, 2023, 09-01, Volume: 35, Issue:9

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Omeprazole; Risk; Stomach Neoplasms

2023
Recent Developments Pertaining to H. pylori Infection.
    The American journal of gastroenterology, 2021, 01-01, Volume: 116, Issue:1

    Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistan

2021
Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation.
    Bioscience reports, 2021, 01-29, Volume: 41, Issue:1

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Antineoplastic Agents; Autophagy; Drug Screening Assa

2021
Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:14

    Topics: Adenomatous Polyps; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; M

2017
The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
    Fitoterapia, 2013, Volume: 89

    Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Pro

2013
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:7

    Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fol

2014
Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
    Cancer letters, 2015, Apr-10, Volume: 359, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Chemokine CXCL10; Chemokine CXCL9; Clarithromycin; Gastric Mucosa; G

2015
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
    BMC research notes, 2015, Apr-15, Volume: 8

    Topics: Adenocarcinoma; Adenoma; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastroscopy; Humans; Male;

2015
Deletion of
    Gut, 2017, Volume: 66, Issue:6

    Topics: Adenocarcinoma; Adult; Animals; Benzodiazepines; Carcinogenesis; Carcinoid Tumor; Cell Line, Tumor;

2017
[Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2008, Volume: 51, Issue:5

    Topics: Aged; Anti-Ulcer Agents; Gastric Fundus; Humans; Male; Omeprazole; Polyps; Stomach Neoplasms

2008
Remission of high-grade B-cell lymphoma in a pediatric patient following Helicobacter pylori eradication.
    Pediatrics international : official journal of the Japan Pediatric Society, 2011, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Drug Therapy, Combination; Helicobacter Infections;

2011
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 58, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Di

2011
[Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment].
    La Tunisie medicale, 2011, Volume: 89, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocol

2011
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.
    Medical molecular morphology, 2012, Volume: 45, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Autophagy; Carcinoid Tumor; Enterochromaffin-like Cells; Female; Histami

2012
Gastric polyps and nodules in children receiving long-term omeprazole therapy.
    Journal of pediatric gastroenterology and nutrition, 2002, Volume: 35, Issue:5

    Topics: Adolescent; Anti-Ulcer Agents; Child; Child, Preschool; Enzyme Inhibitors; Esophagitis, Peptic; Fema

2002
[A case for proton pump blocker... When cough comes from the stomach].
    MMW Fortschritte der Medizin, 2002, Nov-07, Volume: 144, Issue:45

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age

2002
Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination;

2003
[Patient with increased stomach cancer risk. Helicobacter can cause damage here].
    MMW Fortschritte der Medizin, 2002, Oct-24, Volume: 144, Issue:43

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy,

2002
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
    Langenbeck's archives of surgery, 2004, Volume: 389, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; A

2004
Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2004, Volume: 7, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Administration, Oral; Animals; Duodenogastr

2004
The use of subcutaneous omeprazole in the treatment of dyspepsia in palliative care patients.
    Journal of pain and symptom management, 2004, Volume: 28, Issue:6

    Topics: Abdominal Pain; Aged; Anti-Ulcer Agents; Dyspepsia; Enzyme Inhibitors; Female; Humans; Injections, S

2004
Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-15, Volume: 10, Issue:24

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Annexin A5; Anti-Ulcer Agents; Apoptosis; Benzimid

2004
Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils.
    Journal of gastroenterology, 2005, Volume: 40, Issue:1

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Carcinogenicity Tests; Cell Prolifer

2005
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.
    Virchows Archiv : an international journal of pathology, 2005, Volume: 446, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Th

2005
Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anemia, Pernicious; Biopsy, Needle; Carcinoid Tumor; Female

2005
[Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:5

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combin

2005
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Journal of the National Cancer Institute, 2005, Sep-21, Volume: 97, Issue:18

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Progression; Disease-Fre

2005
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
    Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-

2005
[What does the H. pylori eradication bring?].
    MMW Fortschritte der Medizin, 2005, Oct-20, Volume: 147, Issue:42

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Double-Blind Method; Drug

2005
Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
    Helicobacter, 2006, Volume: 11, Issue:1

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; bcl-2-Associated X Protein; Cyclooxygenase 2

2006
[A Case of Cronkhite-Canada syndrome showing resolution with Helicobacter pylori eradication and omeprazole].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2006, Volume: 47, Issue:1

    Topics: Anti-Ulcer Agents; Colonic Polyps; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyp

2006
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
    Journal of experimental & clinical cancer research : CR, 2005, Volume: 24, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer

2005
By the way, doctor. I've been taking Prilosec for over a year for GERD. Recently, I read that long-term use of proton pump inhibitors increases the risk of certain gastric cancers. Your opinion?
    Harvard women's health watch, 2006, Volume: 13, Issue:11

    Topics: Anti-Ulcer Agents; Female; Gastroesophageal Reflux; Humans; Omeprazole; Stomach Neoplasms

2006
Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
    Journal of experimental & clinical cancer research : CR, 2006, Volume: 25, Issue:2

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinati

2006
Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2006, Volume: 55, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents; Calcium; Cell Line, Tumor; Cell M

2006
Hypergastrinemia increases gastric epithelial susceptibility to apoptosis.
    Regulatory peptides, 2008, Feb-07, Volume: 146, Issue:1-3

    Topics: Animals; Anti-Ulcer Agents; Apoptosis; Benzodiazepines; Cells, Cultured; Disease Susceptibility; Gam

2008
Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.
    Cancer science, 2008, Volume: 99, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apoptosis; Caspases; Cell Line, Tumor; Culture Media; Enzym

2008
Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.
    Cancer research, 2008, May-01, Volume: 68, Issue:9

    Topics: Animals; Anti-Infective Agents; Anti-Ulcer Agents; Carcinoma in Situ; Cell Proliferation; Clarithrom

2008
[Changes in therapy of duodenal ulcers. The European Gastro-Club 1983 discusses new pathophysiologic and epidemiologic data referring to drug and surgical therapy].
    Fortschritte der Medizin, 1983, Dec-15, Volume: 101, Issue:47-48

    Topics: Amino Acids; Benzimidazoles; Carbenoxolone; Cimetidine; Duodenal Ulcer; Gastric Acid; Histamine; His

1983
Omeprazole tolerability.
    Drug safety, 1994, Volume: 11, Issue:6

    Topics: Adenocarcinoma; Animals; Humans; Neuroendocrine Tumors; Omeprazole; Rats; Stomach Neoplasms

1994
Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment.
    Zeitschrift fur Gastroenterologie, 1995, Volume: 33, Issue:3

    Topics: Adult; Aged; Cysts; Diagnosis, Differential; Female; Gastric Mucosa; Gastroesophageal Reflux; Humans

1995
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
    Lancet (London, England), 1995, Jun-24, Volume: 345, Issue:8965

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Female; Follow-Up Studies; Gastritis; Helicobacter Infe

1995
[A case of multiple gastric hyperplastic polyps: onset during omeprazole therapy in scleroderma patient].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1994, Volume: 91, Issue:11

    Topics: Aged; Esophagitis, Peptic; Female; Humans; Hyperplasia; Omeprazole; Polyps; Scleroderma, Systemic; S

1994
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
    Zeitschrift fur Gastroenterologie, 1994, Volume: 32, Issue:12

    Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter I

1994
Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication.
    Lancet (London, England), 1995, Mar-25, Volume: 345, Issue:8952

    Topics: Amoxicillin; Biopsy; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-

1995
Hyperplastic polyps following treatment of acute gastric ulcers.
    Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:6

    Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Po

1994
Omeprazole, hypergastrinemia, and gastric carcinoid tumors.
    Annals of internal medicine, 1994, Aug-01, Volume: 121, Issue:3

    Topics: Carcinoid Tumor; Esophagitis, Peptic; Gastrins; Humans; Omeprazole; Stomach Neoplasms

1994
Healing gastric MALT lymphomas by eradicating H pylori?
    Lancet (London, England), 1993, Sep-04, Volume: 342, Issue:8871

    Topics: Amoxicillin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymp

1993
Juvenile gastric polyposis: reduction in blood- and protein-losing gastropathy with omeprazole.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:3

    Topics: Adult; Anemia, Hypochromic; Diagnosis, Differential; Female; Gastritis, Hypertrophic; Humans; Omepra

1994
[What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Fortschritte der Medizin, 1994, Jan-20, Volume: 112, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Carcinogenicity Tests; Carcinoi

1994
Fundic gland polyps: a rare, innocuous, and reversible disturbance.
    Gastroenterology, 1993, Volume: 105, Issue:5

    Topics: Female; Humans; Omeprazole; Polyps; Stomach Neoplasms

1993
[New development on the study of etiological pathology of gastritis, peptic ulcer and stomach cancers in relationship to Helicobacter pylori infection].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Sep-10, Volume: 82, Issue:9

    Topics: Antibodies, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male

1993
Gastric polyposis: onset during long-term therapy with omeprazole.
    The Medical journal of Australia, 1993, Jan-18, Volume: 158, Issue:2

    Topics: Humans; Omeprazole; Polyps; Stomach Neoplasms

1993
Atrophic gastritis and Helicobacter pylori in reflux esophagitis.
    The New England journal of medicine, 1996, Sep-05, Volume: 335, Issue:10

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Esophagitis, Peptic; Gastritis, Atrophic; Helicobacter Inf

1996
Helicobacter pylori, gastric ulcer, and duodenal ulcer.
    The New England journal of medicine, 1996, Dec-12, Volume: 335, Issue:24

    Topics: Age of Onset; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omepr

1996
[A case of gastric MALT lymphoma regressed endoscopically and pathologically after eradication of Helicobacter pylori].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Co

1997
Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori.
    Postgraduate medical journal, 1997, Volume: 73, Issue:856

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infec

1997
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1997, Volume: 6, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose

1997
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
    Journal of the National Cancer Institute, 1997, Sep-17, Volume: 89, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Amoxicillin; Anti-Ulcer Agents; Disease-Free Su

1997
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
    Gastroenterology, 1997, Volume: 113, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Endoscopy; Endosonography; Female; F

1997
Fundic gland polyps developing during omeprazole therapy.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:10

    Topics: Adult; Anti-Ulcer Agents; Barrett Esophagus; Female; Gastric Fundus; Humans; Male; Middle Aged; Omep

1997
Fundic gland polyps: an innocuous curiosity possibly with important pathological associations.
    Human pathology, 1997, Volume: 28, Issue:11

    Topics: Antigens, Nuclear; Biomarkers; Humans; Immunohistochemistry; Nuclear Proteins; Omeprazole; Polyps; P

1997
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:15

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Ba

1997
Gastric acne: omeprazole-induced fundic gland polyposis.
    The Medical journal of Australia, 1998, Jan-19, Volume: 168, Issue:2

    Topics: Gastric Fundus; Gastroscopy; Humans; Omeprazole; Polyps; Stomach Neoplasms

1998
[Gastric lymphoma--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Gastrosc

1998
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
    Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:4

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combinati

1997
Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Carcinoid Tumor; Famotidine; Hist

1998
Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:5

    Topics: Cost of Illness; Decision Support Techniques; Drug Therapy; Duodenal Ulcer; Enzyme Inhibitors; Esoph

1998
Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Endosonography; Fe

1998
Omeprazole and fundic gland polyps.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:5

    Topics: Aged; Anti-Ulcer Agents; Female; Gastric Fundus; Humans; Male; Middle Aged; Omeprazole; Polyps; Stom

1998
The response of early gastric cancer to proton-pump inhibitors.
    The New England journal of medicine, 1998, Jun-25, Volume: 338, Issue:26

    Topics: Adenocarcinoma; Adult; Aged; Diagnostic Errors; Female; Humans; Omeprazole; Proton Pump Inhibitors;

1998
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    The New England journal of medicine, 1998, Jul-30, Volume: 339, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Helicobacter Infections; Helicobacter py

1998
Do fundic gland polyps develop under long-term omeprazole therapy?
    The American journal of gastroenterology, 1998, Volume: 93, Issue:8

    Topics: Adult; Aged; Anti-Ulcer Agents; Female; Gastric Fundus; Humans; Male; Middle Aged; Omeprazole; Polyp

1998
[An unusual course of low-malignancy non-Hodgkin lymphoma of the stomach].
    Zeitschrift fur Gastroenterologie, 1998, Volume: 36, Issue:7

    Topics: Amoxicillin; Biopsy; Combined Modality Therapy; Female; Follow-Up Studies; Gastrectomy; Helicobacter

1998
Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics.
    American journal of clinical pathology, 1998, Volume: 110, Issue:5

    Topics: Endoscopy, Digestive System; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Male; Micro

1998
[Asia Pacific Consensus Conference on the management of Helicobacter pylori].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Asia; Congresses as Topic; Drug Therapy, Combination; Heli

1999
[Gastric MALT lymphoma, clinical features].
    Orvosi hetilap, 1999, Feb-07, Volume: 140, Issue:6

    Topics: Amoxicillin; Anti-Ulcer Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lympho

1999
Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:6

    Topics: Adenocarcinoma; Animals; Anti-Ulcer Agents; Disease Models, Animal; Duodenogastric Reflux; Esophagea

1999
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
    Annals of internal medicine, 1999, Jul-20, Volume: 131, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastroscopy; Helicobac

1999
[Risk of gastric acid inhibition by drugs].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1999, Aug-30, Volume: 119, Issue:20

    Topics: Anti-Ulcer Agents; Enterochromaffin-like Cells; Gastric Acid; Humans; Omeprazole; Risk Factors; Secr

1999
[The risk of cancer induced by omeprazole (Losec) has not increased].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1999, Aug-30, Volume: 119, Issue:20

    Topics: Anti-Ulcer Agents; Enterochromaffin-like Cells; Humans; Omeprazole; Stomach Neoplasms

1999
Fundic gland polyps under omeprazole treatment.
    American journal of clinical pathology, 1999, Volume: 112, Issue:4

    Topics: Anti-Ulcer Agents; Gastric Fundus; Gastroesophageal Reflux; Humans; Omeprazole; Polyps; Stomach Neop

1999
Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication.
    Pathology oncology research : POR, 1999, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biomarkers, Tumor; Drug Therapy, Combinatio

1999
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori.
    Journal of gastroenterology, 1999, Volume: 34 Suppl 11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; A

1999
Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy.
    Gastrointestinal endoscopy, 2000, Volume: 51, Issue:1

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter

2000
[Congress of the American College of Surgeons (ACS). San Francisco, 10-15 October 1999].
    Journal de chirurgie, 1999, Volume: 136, Issue:6

    Topics: Anti-Ulcer Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholang

1999
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome.
    Human pathology, 2000, Volume: 31, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aging; Biopsy; Cell Division; Cysts; Enterochromaffin Cells; Female;

2000
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    The journal of medical investigation : JMI, 2000, Volume: 47, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female

2000
The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach.
    European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:2

    Topics: Achlorhydria; Adult; Carcinogens; Enzyme Inhibitors; Female; Humans; Hydrogen-Ion Concentration; Mal

2000
Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancers.
    Archives of family medicine, 2000, Volume: 9, Issue:4

    Topics: Adult; Aged; Anti-Ulcer Agents; Diagnostic Errors; Endoscopy, Gastrointestinal; Female; Humans; Male

2000
Details of hyperplastic polyps of the stomach shrinking after anti-Helicobacter pylori therapy.
    Journal of gastroenterology, 2000, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers, Tumor; Cell Division; Cyclooxygenase 2; Drug T

2000
Omeprazole in oesophageal reflux disease.
    Lancet (London, England), 2000, Nov-18, Volume: 356, Issue:9243

    Topics: Anti-Ulcer Agents; Carcinoid Tumor; Female; Gastroesophageal Reflux; Humans; Middle Aged; Omeprazole

2000
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
    Gut, 2001, Volume: 48, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer

2001
Long-term omeprazole treatment and risk of gastric cancer.
    Gastroenterology, 2000, Volume: 119, Issue:4

    Topics: Anti-Ulcer Agents; Gastroesophageal Reflux; Humans; Omeprazole; Risk Factors; Stomach Neoplasms

2000
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
    Journal of gastroenterology, 2001, Volume: 36, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; D

2001
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
    Gastrointestinal endoscopy, 2001, Volume: 53, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy,

2001
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Apr-01, Volume: 19, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Fem

2001
The safety of proton pump inhibitors.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:5

    Topics: Carcinoid Tumor; Cell Transformation, Neoplastic; Enzyme Inhibitors; Gastric Acid; Humans; Omeprazol

2001
Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
    International journal of oncology, 2001, Volume: 18, Issue:6

    Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Female; Follow-Up Studies; Genetic Markers; He

2001
Long-term omeprazole treatment and fundic gland polyps: a very authoritative proof against a link?
    The American journal of gastroenterology, 2001, Volume: 96, Issue:5

    Topics: Anti-Ulcer Agents; Drug Administration Schedule; Gastric Fundus; Humans; Omeprazole; Polyps; Stomach

2001
Omeprazole, its isomers, and the carcinoid question.
    Lancet (London, England), 2001, Apr-21, Volume: 357, Issue:9264

    Topics: Animals; Anti-Ulcer Agents; Carcinoid Tumor; Female; Humans; Omeprazole; Rats; Species Specificity;

2001
Gastric leptin and Helicobacter pylori infection.
    Gut, 2001, Volume: 49, Issue:3

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biomarkers; Biopsy; Body Mass Index; Case-Control Studies; Cl

2001
Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole.
    Gastroenterology, 2001, Volume: 121, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Biopsy; Female; Gastric Juice; Helicobacter Infec

2001
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infectio

2001
Remission of a high-grade gastric mucosa associated lymphoid tissue (MALT) lymphoma following Helicobacter pylori eradication and highly active antiretroviral therapy in a patient with AIDS.
    The American journal of medicine, 2001, Volume: 111, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Age

2001
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
    Pathologie-biologie, 2001, Volume: 49, Issue:7

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Dru

2001
Regression of primary high-grade gastric B-cell lymphoma following Helicobacter pylori eradication.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Female; Helicobacter Infections; Helicobacter pylori;

2001
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Nov-15, Volume: 19, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Follo

2001
Optimizing acid-suppression therapy.
    Managed care (Langhorne, Pa.), 2001, Volume: 10, Issue:10 Suppl

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Drug Interactions; Duode

2001
Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
    Journal of gastroenterology, 2002, Volume: 37, Issue:1

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; DNA Methylation;

2002
Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
    Digestion, 2001, Volume: 64, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Gastric Mucosa; Humans; Male;

2001
[Treatment of gastric ulcers with proton pump inhibitors--long-term treatment].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:1

    Topics: Adenosine Triphosphatases; Animals; Depression, Chemical; Gastric Acid; Gastrins; H(+)-K(+)-Exchangi

1992
Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.
    Gut, 1992, Volume: 33, Issue:9

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cimetidine; Cohort Studies; Denmark; Female; Histamine

1992
Gastric polyposis: onset during long-term therapy with omeprazole.
    The Medical journal of Australia, 1992, Nov-02, Volume: 157, Issue:9

    Topics: Gastroscopy; Humans; Long-Term Care; Omeprazole; Polyps; Stomach Neoplasms

1992
Gastric polyposis: onset during long-term therapy with omeprazole.
    The Medical journal of Australia, 1992, Aug-17, Volume: 157, Issue:4

    Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Gastroscopy; Humans; Male; Middle Aged; Omeprazo

1992
Omeprazole.
    BMJ (Clinical research ed.), 1991, Aug-31, Volume: 303, Issue:6801

    Topics: Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Risk Factors; S

1991
Omeprazole.
    BMJ (Clinical research ed.), 1991, Nov-09, Volume: 303, Issue:6811

    Topics: Animals; Gastric Mucosa; Humans; Mutagenesis; Omeprazole; Rats; Stomach Neoplasms

1991
The effect of omeprazole-induced hypergastrinemia on the oxyntic mucosa of mastomys.
    Scandinavian journal of gastroenterology, 1991, Volume: 26, Issue:6

    Topics: Animals; Carcinoid Tumor; Enterochromaffin Cells; Female; Gastric Mucosa; Gastrins; Histamine; Histi

1991
[Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
    Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:4

    Topics: Age Factors; Carcinoid Tumor; Esophagitis, Peptic; Female; Gastrins; Humans; Male; Middle Aged; Omep

1991
Omeprazole: gastrin and gastric data (August 1991)
    Digestive diseases and sciences, 1991, Volume: 36, Issue:10

    Topics: Achlorhydria; Animals; Carcinoid Tumor; Gastrins; Humans; Omeprazole; Rats; Stomach Neoplasms

1991
Potential hazards of long-term acid suppression.
    Scandinavian journal of gastroenterology. Supplement, 1990, Volume: 178

    Topics: Animals; Carcinoid Tumor; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine H2 Antagonists;

1990
Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
    Lancet (London, England), 1989, Apr-08, Volume: 1, Issue:8641

    Topics: Carcinoid Tumor; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Stomach Neoplasms; Zollinger

1989
Antisecretory drugs and gastric cancer.
    British medical journal (Clinical research ed.), 1985, Sep-28, Volume: 291, Issue:6499

    Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Gastric Juice; Histamine H2 Antagonists; Omeprazole; Rat

1985
Omeprazole.
    Lancet (London, England), 1987, Dec-19, Volume: 2, Issue:8573

    Topics: Adenocarcinoma; Adult; Aged; Animals; Esophagitis, Peptic; Humans; Omeprazole; Rats; Stomach Neoplas

1987
Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.
    Toxicologic pathology, 1988, Volume: 16, Issue:2

    Topics: Animals; Carcinogens; Carcinoid Tumor; Enterochromaffin Cells; Female; Gastric Acid; Gastric Mucosa;

1988
[Omeprazole long-term therapy: how great is the risk of developing a carcinoid tumor?].
    Zeitschrift fur Gastroenterologie, 1988, Volume: 26, Issue:12

    Topics: Carcinoid Tumor; Follow-Up Studies; Gastric Mucosa; Humans; Long-Term Care; Omeprazole; Risk Factors

1988
Pharmacology and toxicology of omeprazole--with special reference to the effects on the gastric mucosa.
    Scandinavian journal of gastroenterology. Supplement, 1986, Volume: 118

    Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Carcinoid Tumor; Dogs; Female; Gastric Acid; Gastric Muc

1986
Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion.
    Digestion, 1986, Volume: 35 Suppl 1

    Topics: Animals; Carcinoid Tumor; Chromaffin System; Enterochromaffin Cells; Female; Gastric Mucosa; Gastrin

1986
Toxicological studies on omeprazole.
    Scandinavian journal of gastroenterology. Supplement, 1985, Volume: 108

    Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Carcinogens; Dose-Response Relatio

1985
Antisecretory drugs and gastric cancer.
    British medical journal (Clinical research ed.), 1985, Dec-07, Volume: 291, Issue:6509

    Topics: Achlorhydria; Animals; Benzimidazoles; Humans; Mice; Omeprazole; Rats; Stomach Neoplasms; Triazoles

1985